ImmunityBio (IBRX) Common Equity (2014 - 2026)
ImmunityBio (IBRX) posted Common Equity of -$1.05 billion for Q2 2026, compared with -$569.82 million a year earlier.
Powered by 
Analysis
ImmunityBio (IBRX) Common Equity (2014 - 2026) Analysis & Trends
At the end of FY2025, ImmunityBio's Common Equity came in at -$500.47 million.
- In prior years, ImmunityBio's Common Equity was -$488.13 million in FY2024, -$585.94 million in FY2023, -$449.82 million in FY2022 and -$243.91 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Common Equity in data going back to Q4 2014.
- According to Business Quant data, Common Equity for the three prior quarters was -$869.13 million (Q1 2026), -$500.47 million (Q4 2025) and -$524.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | ImmunityBio | 8.97 Bn | 7.74 Bn | 50.94 Mn | -1.05 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.05 Bn |
| Mar 31, 2026 | -869.13 Mn |
| Dec 31, 2025 | -500.47 Mn |
| Sep 30, 2025 | -524.32 Mn |
| Jun 30, 2025 | -569.82 Mn |
| Mar 31, 2025 | -590.48 Mn |
| Dec 31, 2024 | -488.13 Mn |
| Sep 30, 2024 | -744.16 Mn |
| Jun 30, 2024 | -697.38 Mn |
| Mar 31, 2024 | -690.98 Mn |
| Dec 31, 2023 | -585.94 Mn |
| Sep 30, 2023 | -410.65 Mn |
| Jun 30, 2023 | -645.18 Mn |
| Mar 31, 2023 | -531.72 Mn |
| Dec 31, 2022 | -449.82 Mn |
| Sep 30, 2022 | -429.08 Mn |
| Jun 30, 2022 | -421.97 Mn |
| Mar 31, 2022 | -337.56 Mn |
| Dec 31, 2021 | -243.91 Mn |
| Sep 30, 2021 | -189.94 Mn |
API Access
ImmunityBio Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();